Haemostatic Activation before and after Surgery in Patients with and without Gastric Malignancy

Summary

Pre- and postoperative plasma levels of Prothrombin Fragment 1 + 2 (F₁₊₂), Thrombin-antithrombin III complex (TAT), Fibrinopeptide A (FpA), Fibrin and Fibrinogen Degradation Products (FbDP, FgDP) and Soluble Fibrin (SF) were measured in 40 patients undergoing gastric surgery in order to compare patients operated for benign (n = 21) and malignant (n = 19) disease. Plasma levels of F₁₊₂, TAT, FbDP and SF on the first postoperative day were significantly higher than before operation. F₁₊₂ and FbDP levels were further increased one week after surgery, at which time FgDP levels were also higher than preoperatively. A significant postoperative increase in FpA levels was found only in patients with malignant disease. When age was taken into consideration, significant differences between patients with and without malignancy were found only in the late postoperative period, as cancer patients had higher FpA and FbDP levels one week after surgery and higher FbDP levels one month after discharge from hospital.

• References

• 1 Trousseau A. Clinique Médicale de l’Hôtel-Dieu de Paris. Paris: J. B. Baillière et fils; 1868. (; 3). 95-6 652-95
• 2 Rahr HB, Sørensen JV. Venous thromboembolism and cancer. Blood Coagul Fibrinol 1992; 3: 451-60
• 3 Nieuwenhuizen W, Hoegee-De Nobel E, Laterveer R. A rapid monoclonal antibody-based enzyme immunoassay (EIA) for the quantitative determination of soluble fibrin in plasma. Thromb Haemost 1992; 68: 273-7
• 4 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46
• 5 Kang J, Kambayashi J, Sakon M, Tsujinaka T, Mori T. Postoperative changes in haemostasis analyzed by the serial determination of fibrinopeptides and D-dimer. Japan J Surg 1989; 19: 262-8
• 6 Kambayashi J, Sakon M, Yokota M, Shiba E, Kawasaki T, Mori T. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers. Thromb Res 1990; 60: 157-67
• 7 Wilson J, Grant PJ, Davies JA, Boothby M, Gaffney PJ, Prentice CRM. The relationship between plasma vasopressin and changes in coagulation and fibrinolysis during hip surgery. Thromb Res 1988; 51: 439-45
• 8 Grant PJ, Tate GM, Davies JA, Williams NS, Prentice CRM. Intra-operative activation of coagulation – a stimulus to thrombosis mediated by vasopressin?. Thromb Haemost 1986; 55: 104-7
• 9 Lane DA, Ireland H, Wolff S, Grant R, Jennings S, Allen-Mersh T. Plasma concentrations of fibrinopeptide A, fibrinogen fragment Bβ1-42 and p-thromboglobulin following total hip replacement. Thromb Res 1982; 26: 111-8
• 10 Sorensen JV, Lassen MR, Bonis LC, Rahr HB, Jensen HP, Hoppensteadt D, Walenga JA, Fareed J. Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin. Blood Coagul Fibrinol 1992; 3: 55-9
• 11 Jprgensen LN, Lind B, Hauch O, Leffers A, Albrecht-Beste E, Konradsen LAG. Thrombin-antithrombin III-complex and fibrin degradation products in plasma: surgery and postoperative deep venous thrombosis. Thromb Res 1990; 59: 69-76
• 12 Rowbotham BJ, Whitaker AN, Harrison J, Murtaugh P, Reasbeck P, Bowie EJW. Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis. Blood Coagul Fibrinol 1992; 3: 25-31
• 13 Hoek JA, Nurmohamed MT, ten Cate JW, Btiller HR, Knipscheer HC, Hamelynck KJ, Marti RK, Sturk A. Thrombin-antithrombin Ill-complexes in the prediction of deep vein thrombosis following total hip replacement. Thromb Haemost 1989; 62: 1050-2
• 14 Sprensen JV, Borris LC, Lassen MR, Christiansen HM, Schptt P, Olsen AD. Levels of thrombin-antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low molecular-weight-heparin. Blood Coagul Fibrinol 1990; 1: 389-92
• 15 Abbasciano V, Levato F, Zavagli G. Specificity of fibrinopeptide A (FpA) as a marker for gastrointestinal cancers before and after surgery. Med Oncol Tumor Pharmacother 1987; 4: 75-9
• 16 Douglas JT, Blarney SL, Lowe GDO, Carter DC, Forbes CD. Plasma β-thromboglobulin, Fibrinopeptide A and Bβ15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment. Thromb Haemost 1985; 53: 235-8
• 17 Drewinko B, Schmidt D, Bollinger P, Keating M, Trujillo JM. Coagulation profiles of untreated cancer patients (abstract). Proc Am Soc Clin Oncol 1985; 4: 19
• 18 Nanninga PB, van Teunenbroek A, Veenhof CHN, Bliller HR, ten Cate JW. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer. Thromb Haemost 1990; 64: 361-4